Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Total Payout Yield % is the percent a company has paid to its shareholders through net repurchases of shares and dividends based on its Market Cap. It is a measure of shareholder return.
Solasia Pharma KK Total Payout Yield % Explanation
Similar to Dividend Yield, Total Payout Yield % is a measurement of shareholder return. Dividends is not the only way that companies are able to distribute their excess cash back to the shareholders. The other way to distribute the cash is a stock repurchase. The stock repurchase buys back the company's own shares from the marketplace. This results in a reduced number of oustanding shares, making each share worth a greater percentage of the corporation.
Solasia Pharma KK Total Payout Yield % Related Terms
Solasia Pharma KK Total Payout Yield % Historical Data
* Premium members only.
The historical data trend for Solasia Pharma KK's Total Payout Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4597 vs ZTS, UTHR: Total Payout Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Solasia Pharma KK's Total Payout Yield %, along with its competitors' market caps and Total Payout Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Solasia Pharma KK Total Payout Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Solasia Pharma KK's Total Payout Yield % distribution charts can be found below:
* The bar in red indicates where Solasia Pharma KK's Total Payout Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Solasia Pharma KK (TSE:4597) has a Total Payout Yield % of -13.36 as of Jul. 20, 2026. Total Payout Yield is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Market Cap. View historical data on Solasia Pharma KK and its competitors.
Is Solasia Pharma KK's Total Payout Yield % too high?
Solasia Pharma KK's current Total Payout Yield % is -13.36. Overall, Solasia Pharma KK has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Solasia Pharma KK's Total Payout Yield % compare to ZTS and UTHR?
Solasia Pharma KK's Total Payout Yield % of -13.36 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Payout Yield % for a Drug Manufacturers company?
A good Total Payout Yield % depends on the Drug Manufacturers industry context. However, Total Payout Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Payout Yield % mean?
A high Total Payout Yield % can signal that a stock is expensive relative to its fundamentals. Total Payout Yield is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Market Cap. View historical data on Solasia Pharma KK and its competitors. Solasia Pharma KK's current Total Payout Yield % is -13.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Solasia Pharma KK stock overvalued right now?
Based on GuruFocus' analysis, Solasia Pharma KK (TSE:4597) is currently considered Significantly Overvalued. The stock's GF Value™ is 円2.41, compared to a current price of 円26.00 — trading 978.8% above its estimated fair value. The current Total Payout Yield % is -13.36. Solasia Pharma KK's overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Payout Yield % calculated?
Total Payout Yield % is calculated from a company's financial statements. For Solasia Pharma KK (TSE:4597), the current Total Payout Yield % is -13.36 as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Solasia Pharma KK (TSE:4597) Overvalued in 2026?
Based on GuruFocus' analysis, Solasia Pharma KK stock appears to be overvalued.
The current stock price of 円26.00 is trading 978.8% above its estimated GF Value™ of 円2.41.
GuruFocus considers Solasia Pharma KK to be Significantly Overvalued.
Key valuation signals for TSE:4597:
Total Payout Yield %: -13.36
GF Value™: 円2.41 vs. price of 円26.00 (978.8% above fair value)
No single metric tells the full story. See the TSE:4597 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4597 has been successfully added to your 
